Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05748834
Title Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Maryland Oncology Hematology RECRUITING Columbia Maryland 21044 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Tennessee Oncology ACTIVE_NOT_RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology- DFW RECRUITING Dallas Texas 75246 United States Details
Texas Oncology- San Antonio RECRUITING San Antonio Texas 78240 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
Blue Ridge Cancer Care (Oncology & Hematology Assoc of SW Virginia, Inc) RECRUITING Salem Virginia 24153 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field